Efficacy and safety of fluvastatin 80 mg or valsartan 160 mg and their combination in dyslipidemic patients with arterial hypertension and endothelial dysfunction

Trial Profile

Efficacy and safety of fluvastatin 80 mg or valsartan 160 mg and their combination in dyslipidemic patients with arterial hypertension and endothelial dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Fluvastatin; Valsartan
  • Indications Dyslipidaemias; Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Nov 2011 Actual end date (September 2005) added as reported by ClinicalTrials.gov.
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top